Romania’s electric car market dropped 58% in March compared to 2024, mainly due to the postponement of the implementation of ...
CHMP recommends approval for XOANACYL, an oral therapy for use in the following therapeutic areas: Iron deficiency, chronic renal failure and hyperphosphatemiaFinal European Commission decision ...
Tirzepatide offers a promising treatment for patients with obesity, chronic kidney disease, and heart failure, improving both ...
Independent Newspaper Nigeria on MSN9h
End Stage Kidney DiseaseDr MKO AbimbolaEnd-stage kidney disease is the last stage (5th stage) of chronic kidney disease (CKD). ESRD is also called kidney failure, which develops when the treatment of CKD is either delayed ...
The Kidney Foundation of Central Pennsylvania will provide an educational presentation on chronic kidney disease (CKD) at 1 p ...
Research led by Children's Hospital of Fudan University in China has found that a gene called pancreatic progenitor cell ...
The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection fraction (HFpEF) compared with placebo at one year, ...
For a disease afflicting 35.5 million people in the U.S., chronic kidney disease flies under the radar. Only half the people ...
In patients with heart failure with preserved ejection fraction and obesity, tirzepatide improved clinical outcomes compared ...
Results from the SUMMIT trial suggest that tirzepatide is as effective in preventing heart failure events in those with ...
Novo Nordisk already has broad FDA approvals in hand for its injected semaglutide products Ozempic and Wegovy to reduce the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback